Abstract: A maintenance bag of an ostomy system can include fewer sensors than a diagnostic or analytic ostomy bag that is typically used for newer users. The maintenance bag can include sensors and electronics to detect fill level of the bag. The maintenance bag can also include a bag sealing mechanism that can detect drainage events and help the user to track inventory of the bags. A wafer that can be used with an ostomy bag can include leak sensors configured to detect leak of effluent via a single opening in the hydrocolloid layer that interfaces with skin of a user. The wafer can also include temperature sensors configured to detect inflammation. The wafer can further include a convex interface for better fit with certain users.

Abstract: Examples of the present disclosure provide apparatuses, methods and computer programs for controlling the storage and/or transmission of RA reports. Certain examples provide an apparatus comprising: means for receiving information indicative of a criterion for determining, at least in part, whether a Random Access (RA) report is to be stored and/or transmitted; means for controlling a storage and/or a transmission of the RA report based, at least in part, on the indicated criterion; wherein the criterion is based, at least in part, on a RA configuration associated with the RA report, and wherein the RA configuration comprises RA configuration information for a RA procedure that has been performed and whose information has been logged in the RA report.

Abstract: According to an example embodiment, a method may include logging, by a user device in a wireless network, information related to a multiple-event conditional handover execution, wherein the multiple-event conditional handover execution is based on a joint evaluation of multiple events by the user device; and sending, by the user device, a report including at least a portion of the information.

Abstract: Methods of inhibiting proinflammatory neuroimmune signaling as is related to the treatment of inflammatory disorders are provided. These methods include the inhibiting of toll-like receptor signaling and/or the enhancement of anti-inflammatory signaling, and in one example, the inhibiting of TLR2, TLR4 or TLR7 signaling as well as the enhancement of fracktalkine or IL-10 signaling either alone or together.